FOXO · XBRL financial data
Foxo Technologies financial statements, every fiscal year
The same tables from 8 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (FOXO's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | 0 | 1 | 0 | 4 | 16 |
| Revenue from contracts with customers | — | — | — | 0 | 4 | 16 |
| Cost of revenue | — | 0 | 1 | 0 | — | — |
| Cost of goods and services sold | — | — | 0 | — | — | — |
| Gross profit | — | 0 | 0 | 0 | — | — |
| Research and development | — | 5 | 3 | 1 | 0 | 0 |
| Selling, general and administrative | — | 10 | 27 | 19 | 7 | 11 |
| Total operating expenses | — | 15 | 40 | 22 | 12 | 27 |
| Other operating income (expense) | — | (23) | (55) | — | — | — |
| Operating income (loss) | — | (15) | (40) | (22) | (8) | (10) |
| Interest income | — | 0 | — | — | — | — |
| Interest expense | — | 1 | 1 | 1 | 4 | 3 |
| Other income (expense) | — | (0) | (0) | 0 | (0) | (1) |
| Income tax expense (benefit) | — | — | — | — | — | (0) |
| Net income (loss) | — | (38) | (95) | (26) | (12) | (12) |
- † Share count changed about 104x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Balance sheet
CSVFiscal years (FOXO's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 1 | 1 | 6 | 0 | 0 | 0 |
| Accounts receivable | — | — | — | — | 2 | 2 |
| Inventory | — | 0 | 1 | — | 0 | 0 |
| Prepaid and other current assets | — | — | 3 | — | — | — |
| Total current assets | 2 | 1 | 12 | 0 | 3 | 3 |
| Property and equipment, net | — | 0 | — | 0 | 0 | 0 |
| Right-of-use asset | — | — | — | — | 4 | 4 |
| Goodwill | — | — | — | — | 25 | 28 |
| Total assets | 203 | 202 | 35 | 1 | 42 | 45 |
| Accounts payable | 0 | 0 | 3 | 5 | 7 | 7 |
| Accrued liabilities | — | — | 1 | 2 | 14 | 12 |
| Total current liabilities | 0 | 0 | 7 | 14 | 33 | 29 |
| Lease liability, non-current | — | — | — | — | 4 | 3 |
| Total liabilities | 18 | 12 | 29 | 15 | 36 | 34 |
| Accumulated deficit | (0) | (12) | (147) | (177) | (191) | (225) |
| Total stockholders' equity | (16) | (12) | 7 | (14) | 5 | 11 |
| Total liabilities and equity | 203 | 202 | 35 | 1 | 42 | 45 |
| Common shares outstanding (cover page) millions of shares | — | — | 30 | 11 | 36 | 3,733 |
- † Share count changed about 104x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Cash flows
CSVFiscal years (FOXO's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | — | (38) | (95) | (26) | (12) | (12) |
| Stock-based compensation | — | 0 | 11 | 0 | (0) | (0) |
| Depreciation and amortization | — | — | 1 | 1 | 1 | 1 |
| Net cash from operating activities | — | (1) | (24) | (7) | (3) | (4) |
| Purchases of property and equipment | — | 0 | 0 | — | — | 0 |
| Net cash from investing activities | — | (0) | (2) | — | 0 | (1) |
| Proceeds from issuing common stock | — | — | (31) | — | — | — |
| Proceeds from issuing equity | — | — | — | — | 0 | 3 |
| Net cash from financing activities | — | 14 | 24 | 1 | 3 | 5 |
| Net change in cash | — | (1) | (1) | — | — | — |
- † Share count changed about 104x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Compare with peers
SIC 8731 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8731 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Foxo Technologies | 0.1 | 4.7 | 0.3* | 1.7M | — | 10-QJun 30, 2026 |
| Weed | 0 | 0 | (0)* | 148.3M | 0.1 quarters | 10-QJun 30, 2026 |
| iSpecimen | 4.4 | 0.2 | (0.7)* | 2.5M | 6.4 quarters | 10-QJun 30, 2026 |
| Cannabis Bioscience International Holdings | 0 | 0 | (0)* | 11.6B | 0.0 quarters | 10-QFeb 28, 2026 |
| Hypha Labs | 0 | not reported | (0.1)* | 163.9M | 0.1 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.